Home > Services > Consulting

AIT can provide expert legal testimony and consultation

Our expert toxicologists stand ready to consult with you on specimen collection, drug interactions, and interpretation of test results. Their collective years of professional experience in clinical, forensic, and occupational toxicology also allows them to present objective legal testimony for pending court cases.

AIT’s consulting roster includes clients such as the Federal Bureau of Investigation (FBI), Drug Enforcement Agency (DEA), Food and Drug Administration (FDA), Indiana Department of Corrections (DOC), and various law-enforcement and medical associations.

Want to learn more?
To help us determine which expert best meets your needs or to learn more about AIT’s consulting services, take a few minutes to complete our Consultation Request Form.  You can also contact us at 800-875-3894 or clientservices@aitlabs.com.

To contact our toxicologists with questions about test results, just e-mail them at toxicologist@aitlabs.com.

About Our Experts

Michael A. Evans, Ph.D.   

• Founder and CEO of AIT Laboratories 
• Former Director, Indiana State Department of Toxicology
• Former Professor of Toxicology, Indiana University School of Medicine
• Consultant, National Institute on Drug Abuse
• Member, Society of Forensic Toxicology
• Member, American Men and Women of Science
• Member, Who’s Who of Emerging Leaders in America

Andrea Terrell, Ph.D., DABCC 

• AIT Chief Scientific Officer, Laboratory Director
• Diplomate, American Board of Clinical Chemistry
• Member, Society of Forensic Toxicologists
• Member, American Association of Clinical Chemistry

Scott Kriger, Ph.D. 

• AIT Toxicologist
• Forensic Scientist/Special Agent, Tennessee Bureau of Investigation
• Former Principal Scientist, Hoffman La Roche Pharmaceuticals
• Former Scientist, Solvay Pharmaceuticals
• Member, International Crime Scene Investigation Association
• Member, American Chemical Society
• Member, American Society of Mass Spectrometry
• Member, American Association of Pharmaceutical Scientists
• Member, Society of Forensic Toxicologists

Josh Gunn, Ph.D. 

• AIT Toxicologist
• Bachelor’s degrees in analytical chemistry and forensic science
• Master’s degree in analytical chemistry with research concentration in forensic entomotoxicology
• Ph.D. in analytical chemistry and researching the detection of drugs of  abuse  in meconium
• Member, American Academy of Forensic Sciences (Toxicology)

 Gene Schwilke, Ph.D. candidate 

• AIT Toxicologist
• More than fifteen years of experience in forensic toxicology
• Ph.D. candidate in forensic toxicology at the University of Maryland with research conducted through the National Institute on Drug Abuse (NIDA)
• Dissertation research focuses on plasma concentrations in frequent cannabis users during continuous controlled oral THC administration and predictive models for differentiating recent cannabis use from residual drug excretion
• Worked for eleven years at the Washington State Crime Lab
• Has published articles and given presentations on drugs and impairment on international, national, and regional levels
• Certified by the American Board of Forensic Toxicology (ABFT)

George S. Behonick, Ph.D., DABFT 

• Toxicologist
• Former director of forensic toxicology, UMass Memorial Medical Center Department of Hospital Laboratories
• Former assistant professor of pathology, University of Massachusetts Medical School in Worcester, Mass.
• Former forensic toxicologist, Virginia Department of Forensic Science Western Laboratory
• Diplomate, American Board of Forensic Toxicology
• Bachelor’s degree, The Citadel in Charleston, S.C.
• Master’s degree, Hahnemann University in Philadelphia, Pa.
• Doctorate, St. John’s University in Queens, N.Y.

Lynn R. Willis, Ph.D.

• Pharmacologist
• Former professor of pharmacology in the Department of Pharmacology and Toxicology, Indiana University School of Medicine
• Member, American Society for Pharmacology and Experimental Therapeutics
• Member, American Society of Nephrology
• Member, Controlled Substances Advisory Committee for the Indiana Board of Pharmacy
• Bachelor’s degree in Pharmacy, Oregon State University
• Doctorate in Pharmacology, University of Iowa

AIT Publishes Article About Compliance Monitoring and Risk Mitigation in “Practical Pain Management”

AIT Laboratories Announces New Headquarters

AIT CEO Joins Board of Directors for newly formed Perfinity BioSciences